What's new

Human medicines European public assessment report (EPAR): Avamys, fluticasone furoate, Date of authorisation: 11/01/2008, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Avamys, fluticasone furoate, Date of authorisation: 11/01/2008, Revision: 24, Status: Authorised

Feb 18, 2025 - 17:06
 0
Human medicines European public assessment report (EPAR): Avamys, fluticasone furoate, Date of authorisation: 11/01/2008, Revision: 24, Status: Authorised
Human medicines European public assessment report (EPAR): Avamys, fluticasone furoate, Date of authorisation: 11/01/2008, Revision: 24, Status: Authorised
Read More

Tags:

Previous Article

Report: Some Hyundai and Kia EVs to Regain Tax Credit Eligibility This Year

Next Article

Human medicines European public assessment report (EPAR): Cimzia, certolizumab p...

Related Posts

Orphan designation: Alvelestat Treatment of congenital alpha-1 antitrypsin deficiency, 16/01/2025 Positive

Orphan designation: Alvelestat Treatment of congenital ...

Feb 20, 2025  0

Orphan designation: Humanised monoclonal antibody targeting B-cell maturation antigen conjugated with maleimidocaproyl monomethyl auristatin F Treatment of multiple myeloma, 16/10/2017 Withdrawn

Orphan designation: Humanised monoclonal antibody targe...

Feb 19, 2025  0

EMEA-003507-PIP01-23

EMEA-003507-PIP01-23

Feb 13, 2025  0